Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES STRIDES PHARMA SCIENCE ZYDUS LIFESCIENCES/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 20.6 -51.1 - View Chart
P/BV x 2.4 1.4 177.7% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 ZYDUS LIFESCIENCES   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-22
STRIDES PHARMA SCIENCE
Mar-22
ZYDUS LIFESCIENCES/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs674947 71.2%   
Low Rs331305 108.7%   
Sales per share (Unadj.) Rs149.1341.9 43.6%  
Earnings per share (Unadj.) Rs22.7-40.5 -56.1%  
Cash flow per share (Unadj.) Rs29.7-14.5 -204.4%  
Dividends per share (Unadj.) Rs2.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs166.1262.5 63.3%  
Shares outstanding (eoy) m1,023.7489.79 1,140.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.41.8 184.1%   
Avg P/E ratio x22.1-15.5 -143.0%  
P/CF ratio (eoy) x16.9-43.1 -39.3%  
Price / Book Value ratio x3.02.4 126.9%  
Dividend payout %11.00-   
Avg Mkt Cap Rs m514,27756,177 915.5%   
No. of employees `000NANA-   
Total wages/salary Rs m21,7776,469 336.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m152,65230,703 497.2%  
Other income Rs m2,3541,320 178.3%   
Total revenues Rs m155,00632,022 484.1%   
Gross profit Rs m34,427-2,639 -1,304.4%  
Depreciation Rs m7,1302,330 306.0%   
Interest Rs m1,2701,767 71.9%   
Profit before tax Rs m28,381-5,417 -523.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,117-1,783 -287.0%   
Profit after tax Rs m23,264-3,634 -640.1%  
Gross profit margin %22.6-8.6 -262.3%  
Effective tax rate %18.032.9 54.8%   
Net profit margin %15.2-11.8 -128.7%  
BALANCE SHEET DATA
Current assets Rs m122,61433,618 364.7%   
Current liabilities Rs m78,39434,117 229.8%   
Net working cap to sales %29.0-1.6 -1,784.3%  
Current ratio x1.61.0 158.7%  
Inventory Days Days9392 100.7%  
Debtors Days Days80144 55.6%  
Net fixed assets Rs m144,38233,989 424.8%   
Share capital Rs m1,024898 114.0%   
"Free" reserves Rs m168,97222,670 745.4%   
Net worth Rs m169,99623,568 721.3%   
Long term debt Rs m3,6218,356 43.3%   
Total assets Rs m266,99667,607 394.9%  
Interest coverage x23.3-2.1 -1,130.7%   
Debt to equity ratio x00.4 6.0%  
Sales to assets ratio x0.60.5 125.9%   
Return on assets %9.2-2.8 -332.8%  
Return on equity %13.7-15.4 -88.7%  
Return on capital %17.1-11.4 -149.4%  
Exports to sales %060.7 0.0%   
Imports to sales %14.30-   
Exports (fob) Rs mNA18,639 0.0%   
Imports (cif) Rs m21,869NA-   
Fx inflow Rs m63,06519,390 325.2%   
Fx outflow Rs m21,869529 4,135.4%   
Net fx Rs m41,19618,861 218.4%   
CASH FLOW
From Operations Rs m21,041-2,578 -816.1%  
From Investments Rs m11,544-1,187 -972.3%  
From Financial Activity Rs m-8,6834,213 -206.1%  
Net Cashflow Rs m23,729449 5,285.3%  

Share Holding

Indian Promoters % 75.0 30.8 243.4%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 15.5 36.9 42.1%  
FIIs % 2.6 21.4 12.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 68.9 36.3%  
Shareholders   408,231 130,682 312.4%  
Pledged promoter(s) holding % 0.0 70.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    LUPIN    AUROBINDO PHARMA    


More on Cadila Healthcare vs STRIDES PHARMA SCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs STRIDES PHARMA SCIENCE Share Price Performance

Period Cadila Healthcare STRIDES PHARMA SCIENCE S&P BSE HEALTHCARE
1-Day 1.49% 1.48% -0.89%
1-Month -8.17% 14.26% -1.85%
1-Year -10.96% -22.76% -6.83%
3-Year CAGR 16.63% -1.19% 20.56%
5-Year CAGR -0.30% -14.78% 10.73%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the STRIDES PHARMA SCIENCE share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of STRIDES PHARMA SCIENCE the stake stands at 31.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of STRIDES PHARMA SCIENCE.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of 11.0%.

STRIDES PHARMA SCIENCE paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of STRIDES PHARMA SCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 4-Day Losing Streak, Gains 160 Points | Bank Nifty Gains 1% to Hit Record High | PSU Bank Stocks Rally(Closing)

After opening the day on a flat note, Indian share markets extended gains during the last hour of trade to end higher.